OR WAIT null SECS
January 22, 2019
The company has built a fit-for-purpose liquid chromatography–mass spectrometry (LC–MS) system to streamline analytical monitoring tests for biopharmaceuticals.
January 07, 2019
A new plasma B cell antibody discovery workflow launched by Berkeley Lights enables the shortening of antibody drug discovery from month to a day.
The new reagents are designed to support clinical-phase and commercialization stages of cell and gene therapy production and to enhance DNA transfection.
The Steritest NEO device from MilliporeSigma provides safer pharmaceutical product testing through additional features.
December 10, 2018
The company will use GE Healthcare’s off-the-shelf KUBio biologics factory, which is expected to start operations in 2020, to provide development and manufacturing for early- to late-clinical and early-commercial manufacturing stages.
December 05, 2018
Integration of two separate chromatography data systems boosts workflow efficiency.
November 29, 2018
Charles River Laboratories has announced a data expansion in its compendium of tumor models for oncology drug R&D.
A new, high-throughput microplate reader cuts down on screening time and works faster than standard ultra-high-performance liquid chromatography processes.
The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.
The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.